Novo Integrated Sciences
NVOS
#10601
Rank
HK$0.32 M
Marketcap
HK$0.01634
Share price
110.00%
Change (1 day)
-96.50%
Change (1 year)

Revenue for Novo Integrated Sciences (NVOS)

Revenue in 2024 (TTM): HK$0.10 Billion

According to Novo Integrated Sciences's latest financial reports the company's current revenue (TTM ) is HK$0.10 Billion. In 2023 the company made a revenue of HK$0.10 Billion an increase over the revenue in the year 2022 that were of HK$93.72 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novo Integrated Sciences from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) HK$0.10 B3.79%
2023 HK$0.10 B8.7%
2022 HK$93.72 M16.56%
2021 HK$80.4 M38.9%
2020 HK$57.88 M-23.04%
2019 HK$75.22 M7.3%
2018 HK$70.1 M36.7%
2017 HK$51.28 M
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Select Medical Holdings
SEM
HK$30.60 B 29,001.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Integrated Sciences
NVOS
HK$0.10 B 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HealthSouth
EHC
HK$45.09 B 42,776.51%๐Ÿ‡บ๐Ÿ‡ธ USA